These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39325659)

  • 1. Hybrid Somatostatin Receptor PET/MRI of the Head and Neck.
    Keir G; Petrover D; Caravella C; Goenka A; Rini JN; Franceschi AM
    Radiographics; 2024 Oct; 44(10):e240020. PubMed ID: 39325659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin Receptor-PET/CT/MRI of Head and Neck Neuroendocrine Tumors.
    Rini JN; Keir G; Caravella C; Goenka A; Franceschi AM
    AJNR Am J Neuroradiol; 2023 Aug; 44(8):959-966. PubMed ID: 37442593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
    Janssen I; Chen CC; Taieb D; Patronas NJ; Millo CM; Adams KT; Nambuba J; Herscovitch P; Sadowski SM; Fojo AT; Buchmann I; Kebebew E; Pacak K
    J Nucl Med; 2016 Feb; 57(2):186-91. PubMed ID: 26564322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited Commentary: Application of Hybrid Somatostatin Receptor PET/MRI of the Head and Neck.
    Shatzkes DR; Strauss SB
    Radiographics; 2024 Oct; 44(10):e240224. PubMed ID: 39325657
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging of neuroendocrine tumors.
    Rufini V; Calcagni ML; Baum RP
    Semin Nucl Med; 2006 Jul; 36(3):228-47. PubMed ID: 16762613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of positron emission tomography in thyroid and neuroendocrine tumors.
    Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
    Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
    Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor PET beyond the neuroendocrine tumors of the gastrointestinal tract - the review of literature.
    Zogala D
    Klin Onkol; 2021; 34(4):291-299. PubMed ID: 34905930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/MRI vs PET/CT in Head and Neck Imaging: When, Why, and How?
    Ryan JL; Aaron VD; Sims JB
    Semin Ultrasound CT MR; 2019 Oct; 40(5):376-390. PubMed ID: 31635765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
    King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms.
    Ambrosini V; Fortunati E; Fanti S; Ursprung S; Asmundo L; O'Shea A; Kako B; Lee S; Furtado FS; Blake M; Goiffon RJ; Najmi Z; Hesami M; Murakami T; Domachevsky L; Catalano OA
    J Comput Assist Tomogr; 2024 Jul-Aug 01; 48(4):510-520. PubMed ID: 38518197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
    Shamim SA; Kumar A; Kumar R
    PET Clin; 2015 Jul; 10(3):411-21. PubMed ID: 26099675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results.
    Demirci E; Ocak M; Kabasakal L; Araman A; Ozsoy Y; Kanmaz B
    Nucl Med Commun; 2013 Aug; 34(8):727-32. PubMed ID: 23728519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.
    Gabriel M; Oberauer A; Dobrozemsky G; Decristoforo C; Putzer D; Kendler D; Uprimny C; Kovacs P; Bale R; Virgolini IJ
    J Nucl Med; 2009 Sep; 50(9):1427-34. PubMed ID: 19690033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from
    Weber M; Kessler L; Schaarschmidt B; Fendler WP; Lahner H; Antoch G; Umutlu L; Herrmann K; Rischpler C
    BMC Cancer; 2020 Apr; 20(1):326. PubMed ID: 32299391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.
    Blanchet EM; Millo C; Martucci V; Maass-Moreno R; Bluemke DA; Pacak K
    Clin Nucl Med; 2014 Mar; 39(3):243-50. PubMed ID: 24152658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular imaging of head and neck cancers : Perspectives of PET/MRI].
    Stumpp P; Purz S; Sabri O; Kahn T
    Radiologe; 2016 Jul; 56(7):588-96. PubMed ID: 27306200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.
    Binderup T; Knigge U; Loft A; Mortensen J; Pfeifer A; Federspiel B; Hansen CP; Højgaard L; Kjaer A
    J Nucl Med; 2010 May; 51(5):704-12. PubMed ID: 20395333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.